Mikes G.
- Country
- Greece
- Department
- Opthalmology Clinic
Research Overview
- A Non-Inferiority Study Comparing Brimonidine Tartrate and Timolol Fixed-Dose Combination Eye Drops to an Active Comparator in Patients with Open-Angle Glaucoma or Ocular Hypertension
- Non-Inferiority Trial of Brinzolamide-Timolol Versus Azarga in Reducing Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension
- Non-Inferiority Trial of Brimonidine Tartrate/Timolol Maleate Eye Drops Versus Combigan in Open-Angle Glaucoma or Ocular Hypertension Patients
Data & Insights
Has run more than one trial at 13 of 20 partner sites.
Specializations
Ophthalmic Research
The investigator specializes in treating ocular hypertension and various forms of glaucoma, with particular emphasis on open angle glaucoma management.
- Intraocular Pressure Management
- Glaucoma Treatment Optimization
- Optic Disk Pathology
The research focus includes evaluating innovative therapeutic approaches for pressure reduction in the eye.
Therapeutic Applications
The investigator studies fixed-combination eye drop formulations for treating elevated intraocular pressure conditions, examining both established and novel therapeutic solutions.
- Combination Drug Therapies
- Preservative-containing Solutions
- Single-dose Applications
Research activities center on comparative assessments of various ophthalmic formulations for pressure management.
Clinical Assessment
Expertise in evaluating diurnal intraocular pressure patterns and conducting detailed assessments of visual field defects in patients with ocular conditions.
- Pressure Measurement Techniques
- Visual Field Analysis
- Treatment Efficacy Assessment
The investigator focuses on comprehensive evaluation methods for monitoring treatment outcomes in ophthalmic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.